251 related articles for article (PubMed ID: 21348559)
21. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
22. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
[TBL] [Abstract][Full Text] [Related]
23. Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus.
Sicras-Mainar A; Navarro-Artieda R; Morano R; Ruíz L
Endocrinol Nutr; 2016 Dec; 63(10):527-535. PubMed ID: 27744013
[TBL] [Abstract][Full Text] [Related]
24. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
; Nicolucci A; Maione A; Franciosi M; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E
Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
[TBL] [Abstract][Full Text] [Related]
25. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
Jarosz-Chobot P
Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
[TBL] [Abstract][Full Text] [Related]
26. A comparison of costs for four oral antidiabetic regimens within a managed care population.
Stockl K; Vanderplas AM; Nicklasson L
Manag Care Interface; 2003 Jul; 16(7):31-6. PubMed ID: 12908215
[TBL] [Abstract][Full Text] [Related]
27. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537
[TBL] [Abstract][Full Text] [Related]
28. Real-World Costs of Continuous Insulin Pump Therapy and Multiple Daily Injections for Type 1 Diabetes: A Population-Based and Propensity-Matched Cohort From the Swedish National Diabetes Register.
Toresson Grip E; Svensson AM; Miftaraj M; Eliasson B; Franzén S; Gudbjörnsdottir S; Steen Carlsson K
Diabetes Care; 2019 Apr; 42(4):545-552. PubMed ID: 30705062
[TBL] [Abstract][Full Text] [Related]
29. Continuous insulin infusion systems in type 2 diabetes.
Kesavadev J
J Assoc Physicians India; 2011 Apr; 59 Suppl():41-3. PubMed ID: 21818997
[TBL] [Abstract][Full Text] [Related]
30. Comparing insulin vials to pens--comparison of charges, not healthcare benefits.
Thethi TK
J Med Econ; 2013 Oct; 16(10):1228-30. PubMed ID: 23926888
[No Abstract] [Full Text] [Related]
31. Role of Devices in Insulin Delivery.
Meneghini LF; McNulty JN
Diabetes Technol Ther; 2017 Feb; 19(2):76-78. PubMed ID: 28118052
[No Abstract] [Full Text] [Related]
32. Healthcare utilization changes in relation to treatment intensification with insulin aspart in patients with type 2 diabetes. Data from a large US managed-care organization.
Aagren M; Luo W; Moës E
J Med Econ; 2010 Mar; 13(1):16-22. PubMed ID: 19958212
[TBL] [Abstract][Full Text] [Related]
33. Effect of insulin pen devices on the management of diabetes mellitus.
Meece J
Am J Health Syst Pharm; 2008 Jun; 65(11):1076-82. PubMed ID: 18499883
[No Abstract] [Full Text] [Related]
34. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion.
Fujikawa T; Imbe H; Date M; Go Y; Kitaoka H
Diabetes Res Clin Pract; 2012 Aug; 97(2):e31-3. PubMed ID: 22609054
[TBL] [Abstract][Full Text] [Related]
35. Costs of treatment and complications of adult type 1 diabetes.
Franciosi M; Lucisano G; Amoretti R; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Vitacolonna E; Nicolucci A
Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):606-11. PubMed ID: 22749531
[TBL] [Abstract][Full Text] [Related]
36. Increased healthcare utilization costs following initiation of insulin treatment in type 2 diabetes: A long-term follow-up in clinical practice.
Kalkan A; Bodegard J; Sundström J; Svennblad B; Östgren CJ; Nilsson PN; Johansson G; Ekman M
Prim Care Diabetes; 2017 Apr; 11(2):184-192. PubMed ID: 27894781
[TBL] [Abstract][Full Text] [Related]
37. [EFFECTIVENESS OF PUMP INSULIN THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (REVIEW)].
Seidinova A; Ishigov I; Peyami C; Seidinov S
Georgian Med News; 2018 Nov; (284):51-55. PubMed ID: 30618389
[TBL] [Abstract][Full Text] [Related]
38. Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery.
Makary MA; Clark JM; Shore AD; Magnuson TH; Richards T; Bass EB; Dominici F; Weiner JP; Wu AW; Segal JB
Arch Surg; 2010 Aug; 145(8):726-31. PubMed ID: 20713923
[TBL] [Abstract][Full Text] [Related]
39. Clinical and Economic Outcomes of Patients with Type 2 Diabetes on Multiple Daily Injections of Basal-bolus Insulin (MDI) Therapy: A Retrospective Cohort Study.
Brixner D; Ermakova A; Xiong Y; Sieradzan R; Sacks N; Cyr P; Taylor SD
Clin Ther; 2019 Feb; 41(2):303-313.e1. PubMed ID: 30709610
[TBL] [Abstract][Full Text] [Related]
40. Insulin pump use in type 2 diabetes.
Bode BW
Diabetes Technol Ther; 2010 Jun; 12 Suppl 1(Suppl 1):S17-21. PubMed ID: 20515301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
